Las Vegas, NV -- (SBWIRE) -- 10/31/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Angie's List Inc (NASDAQ:ANGI), Keryx Biopharmaceuticals (NASDAQ:KERX), Zogenix, Inc. (NASDAQ:ZGNX), Olin Corporation (NYSE:OLN)
Angie's List Inc (NASDAQ:ANGI) managed to keep its gain at 2.55% on below -normal volume of 1.79M shares. The stock settled at $14.86 after floating in a range of $14.45 to $15.15. Its latest price has reached market capitalization of $14.86 million. Its 52-week range has been $9.69 to $28.32. Angie’s List, Inc. (Angie’s List) operates a consumer-driven service for members to research, hire, rate and review local professionals for critical needs, such as home, health care and automotive services.
For How Long ANGI will fight for Profitability? Read This Trend Analysis report
Keryx Biopharmaceuticals (NASDAQ:KERX) traded down on a volume of 1.79 million, lower than its standard daily volume. Shares have dropped-4.36% to $10.32. Over the last twelve months, the stock has lost-4.53% and faced a worst price of $2.23. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
Has KERX Found The Bottom And Ready To Gain Momentum? Find Out Here
Zogenix, Inc. (NASDAQ:ZGNX) settled 0.34% higher at $2.99 on below -normal volume of 1.78M shares during the last trading day. The stock has its 12-month high at $3.45 and 52-week low price was $1.11. It traded in a range of $2.93 to $3.09 during the last trading day. Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain.
Why Should Investors Buy ZGNX After the Recent Fall? Just Go Here and Find Out
In the last trading session, Olin Corporation (NYSE:OLN) was down on high volume, trading at a volume of 1.78M versus its average daily volume of 1.14 million shares. At $22.68, the stock has attained market capitalization of 1.81 billion. Olin Corporation is a manufacturer focused in three business segments: Chlor Alkali Products, Chemical Distribution and Winchester.
Why Should Investors Buy OLN After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)